Company intelligence / Profile preview

Xcardia Innovation

Rehovot, Israel

Ownership: Private
Development stage: Other

Overview

Xcardia Innovation is a private Israeli cardiovascular medical device company developing tools for extraction of implanted cardiac leads and related intravascular objects. Its lead product, Xtractor, is a steerable, motor-assisted extraction device designed to facilitate removal of pacemaker and defibrillator leads through percutaneous procedures. The device received U.S. FDA 510(k) clearance in February 2022 and was subsequently reported in first-in-human clinical use. The company appears focused on interventional electrophysiology and cardiac rhythm management procedures rather than therapeutics or drug development.

Therapeutic areas: CardiovascularOther
Modalities: Device
Industry: Surgical Medical Devices

Partnerships

Johns Hopkins Hospital

Beyond the preview

Go deeper on Xcardia Innovation.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Xcardia Innovation.

Explore the full profile